Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
HIV Medicine|March 16, 2017
Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infectionJ Brown, J A McGowan, H Chouial, et al.
AIDS (London, England)|April 13, 1999
Virological response to protease inhibitor therapy in an HIV clinic cohortS Staszewski, V Miller, C Sabin, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2008
What is the risk of mortality following diagnosis of multidrug-resistant HIV-1?D Grover, A Copas, H Green, et al.
HIV Medicine|November 30, 2005
Determinants of response to first HAART regimen in antiretroviral-naïve patients with an estimated time since HIV seroconversionR Thiébaut, H Jacqmin-Gadda, S Walker, et al.
AIDS (London, England)|December 12, 2001
Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individualsA N Phillips, V Miller, C Sabin, et al.
European Journal of Pharmacology|July 22, 1998
Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in ratsM S Chintala, P J Chiu, V Bernadino, et al.
Peerj|October 23, 2019
Combining simulation modeling and stable isotope analyses to reconstruct the last known movements of one of Nature's giantsClive N Trueman, Andrew L Jackson, Katharyn S Chadwick, et al.
AIDS (London, England)|June 17, 1999
Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapyS Staszewski, V Miller, C Sabin, et al.
The Journal of Infectious Diseases|July 9, 1999
CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus loadV Miller, S Staszewski, C Sabin, et al.
Clinical and Experimental Immunology|May 1, 1992
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosisM Bofill, G Janossy, C A Lee, et al.
Pageof 11